ANDREA BOLESTA: Open Payments
NPI 1467733816 · EXTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 30 payments from 10 companies in 2025. Trend: 2023 $111 · 2024 $357 · 2025 $900
Food & beverage: $722Education: $177
| Company | Payments | Amount |
|---|---|---|
| HARMONY BIOSCIENCES LLC | 6 | $244 |
| Regeneron Healthcare Solutions, Inc. | 9 | $171 |
| Lilly USA, LLC | 2 | $139 |
| GlaxoSmithKline, LLC. | 3 | $126 |
| AERIN MEDICAL INC. | 3 | $83 |
| JAZZ PHARMACEUTICALS INC. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $29 |
| Optinose US, Inc. | 1 | $26 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $14 |
Products named: DUPIXENT, WAKIX, ZEPBOUND, NUCALA, VIVAER STYLUS, XYWAV, Sunosi, NEFFY.
Industry payments across PA — which companies pay providers there.
